[1] New trends in patient management: risk-based therapy for febrile patients with neutropenia

[2] Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

[3] Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

[4] In vitro activity of ertapenem against bacterial isolates from cancer patients

[5] Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin

[6] Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer

[7] Anxiety and depression in working-age cancer survivors: a register-based study

[8] Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment